These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37645440)

  • 1. Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial.
    Yalçın N; Kaşıkcı M; Çelik HT; Allegaert K; Demirkan K; Yiğit Ş
    Front Pharmacol; 2023; 14():1242779. PubMed ID: 37645440
    [No Abstract]   [Full Text] [Related]  

  • 2. Handling drug-related problems in rehabilitation patients: a randomized study.
    Willoch K; Blix HS; Pedersen-Bjergaard AM; Eek AK; Reikvam A
    Int J Clin Pharm; 2012 Apr; 34(2):382-8. PubMed ID: 22388601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determine the impact of a structured pharmacist-led medication review - a controlled intervention study to optimise medication safety for residents in long-term care facilities.
    Lexow M; Wernecke K; Sultzer R; Bertsche T; Schiek S
    BMC Geriatr; 2022 Apr; 22(1):307. PubMed ID: 35397527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial.
    Bektay MY; Sancar M; Okyaltirik F; Durdu B; Izzettin FV
    Front Pharmacol; 2022; 13():1049289. PubMed ID: 36703759
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
    Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
    J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial.
    Varas-Doval R; Gastelurrutia MA; Benrimoj SI; García-Cárdenas V; Sáez-Benito L; Martinez-Martínez F
    Pharm Pract (Granada); 2020; 18(4):2133. PubMed ID: 33149794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
    Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
    J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.
    Zaal RJ; Jansen MM; Duisenberg-van Essenberg M; Tijssen CC; Roukema JA; van den Bemt PM
    Int J Clin Pharm; 2013 Oct; 35(5):753-62. PubMed ID: 23715760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utilising statutory health insurance data to evaluate pharmaceutical interventions in secondary care - a pilot study].
    Wilke D; Schiek S; Bertsche T; Knoth H
    Z Evid Fortbild Qual Gesundhwes; 2017 Apr; 121():21-28. PubMed ID: 28351625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinical Pharmacist-led Approach on Reducing Drug Related Problems Among Patients with Neurological Disorders: An Interventional Study.
    Jimmy N; Upadhya M; Jaison JM; Sidheque S; Sundaramurthy H; Nemichandra SC; Paneyala S; Ramesh M; Sri Harsha C; Syed J; Pal N
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100302. PubMed ID: 37538991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug related problems in the neonatal intensive care unit: incidence, characterization and clinical relevance.
    Leopoldino RD; Santos MT; Costa TX; Martins RR; Oliveira AG
    BMC Pediatr; 2019 Apr; 19(1):134. PubMed ID: 31027487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions.
    Zhang S; Zhang GB; Huang P; Ren Y; Lin B; Shao YF; Ye XL
    BMC Geriatr; 2023 Dec; 23(1):849. PubMed ID: 38093184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
    Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
    J Oncol Pharm Pract; 2021 Oct; 27(7):1644-1656. PubMed ID: 33040675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
    Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
    BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia.
    Sagita VA; Bahtiar A; Andrajati R
    Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e81-e87. PubMed ID: 29666686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management.
    Freyer J; Kasprick L; Sultzer R; Schiek S; Bertsche T
    Int J Clin Pharm; 2018 Oct; 40(5):1189-1198. PubMed ID: 30051223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of patient factors and medications for drug-related problems from a prospective longitudinal study of newborns admitted to a neonatal intensive care unit in Brazil.
    Leopoldino RD; Santos MT; Costa TX; Martins RR; Oliveira AG
    BMJ Open; 2019 Jul; 9(7):e024377. PubMed ID: 31296505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of telepharmacy on hypertension management in the United Arab Emirates.
    Ibrahim OM; Meslamani AZA; Ibrahim R; Kaloush R; Mazrouei NA
    Pharm Pract (Granada); 2022; 20(4):2734. PubMed ID: 36793920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability.
    Ahmed NA; Fouad EA; El-Asheer OM; Ghanem ASM
    Front Pharmacol; 2024; 15():1391657. PubMed ID: 38873432
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit.
    Polat EC; Koc A; Demirkan K
    J Clin Pharm Ther; 2022 Dec; 47(12):2287-2294. PubMed ID: 36394173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.